Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa In The News.
Press releases published on August 25, 2025
VRIZE Celebrates 5 Years of Transforming Enterprises Worldwide
A milestone of global impact, strategic partnerships, and transformative solutions across industries. TAMPA, FL, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- VRIZE, a global leader in frictionless digital engineering, proudly celebrates its …
Weber Legal Nurse Consulting to Exhibit at CAALA Vegas, an Annual Conference of Consumer Attorneys, August 28-31
Weber Legal Nurse Consulting CEO Silvia Aninye to answer questions on how patients benefit when consumer attorneys work with legal nurse consultants. LAS VEGAS, NV, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- An estimated 3000 consumer …
Integral Metals Announces Closing of Private Placement Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce that it …
Heifer International Calls for Local, Youth-Led Solutions at Africa Food Systems Forum 2025
Global nonprofit urges urgent action to back youth innovators, unlock catalytic finance, and scale locally led solutions as 307 million Africans face hunger. DAKAR, SENEGAL, August 25, 2025 /EINPresswire.com/ -- With Africa facing a worsening hunger …
PayLogic Announces the Go-Live of the Comoros’s National Interoperable Payment Switch
PayLogic today announced the successful go-live of the Comoros’s National Payment Switch, a major milestone in strengthening the financial infrastructure. CASABLANCA, MOROCCO, August 25, 2025 /EINPresswire.com/ -- PayLogic today announced the …
Kyverna Therapeutics to Present at Upcoming Investor Conferences in September
EMERYVILLE, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that Warner Biddle, …
Praxis Medicines to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy Pipeline
BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system (CNS) disorders, today announced its participation in the …
New Website to Keep Up with the Demand for Online Pet Food Delivery in South Africa
Zuki launches a new website to meet growing demand for affordable, trusted online pet food delivery in South Africa JOHANNESBURG, GAUTENG, SOUTH AFRICA, August 25, 2025 /EINPresswire.com/ -- Zuki, a well-established online pet store serving dog and cat …
XS.com Ganha o Prêmio de “Melhor Pesquisa de Mercado” no Money Expo India 2025
BRAZIL, August 25, 2025 /Business News/ -- A XS.com, a principal empresa global de FinTech e corretora multiativos, foi premiada com o título de “Melhor Pesquisa de Mercado” no Money Expo India 2025, realizado nos dias 23 e 24 de agosto no Jio World …
Palisade Bio Releases Virtual Investor KOL Connect Segment on FSCD and Lead Candidate PALI-2108
– Moderated discussion with leading expert in Fibrostenotic Crohn's Disease (FSCD) and Inflammatory Bowel Diseases (IBD), Dr. Brian Feagan – Segment provides further insight into the need for more effective treatment options for FSCD and how PALI-2108 may …
PDS Biotech Announces Final Topline Survival Data from VERSATILE-002 Phase 2 Trial in Head and Neck Cancer
Median Overall Survival (mOS) of 39.3 months in patients with CPS ≥ 1 – best published result with standard of care pembrolizumab or pembrolizumab + chemotherapy is 17.9 months* VERSATILE-003 Phase 3 trial in progress PRINCETON, N.J., Aug. 25, 2025 (GLOBE …
Biofrontera Inc. Announces Last-Patient-Out in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris
Final patient visit marks key milestone for Biofrontera, with top-line results expected Q1 2026 Company plans FDA discussion in Q3 2026 to advance Phase 3 program and potential label expansion More than 50 million people affected by acne in US each year, …
24/7 Market News: LIXTE Targets Large, Unmet Oncology Markets
DENVER, Aug. 25, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, revisits LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage …
SCYNEXIS to Participate in the H.C. Wainwright 27th Annual Global Conference September 8 – 10, 2025
JERSEY CITY, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that the Scynexis senior …
Avalyn to Participate in Multiple Upcoming Investor Conferences in September
CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on the development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced that management …
Ardelyx to Participate in Upcoming Investor Conferences
WALTHAM, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
Fate Therapeutics to Present at Upcoming Investor Conferences
SAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular …